Literature DB >> 18338763

Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.

Maarit Lappalainen1, Leena Halme, Ulla Turunen, Päivi Saavalainen, Elisabet Einarsdottir, Martti Färkkilä, Kimmo Kontula, Paulina Paavola-Sakki.   

Abstract

BACKGROUND: Crohn's disease (CD) and ulcerative colitis (UC), 2 major forms of inflammatory bowel disease (IBD), are complex disorders with significant genetic predisposition. The first CD-associated gene, CARD15/NOD2, was recently identified and since then several reports on novel IBD candidate genes have emerged. We investigated disease phenotype association to genetic variations in IL23R, ATG16L1, DLG5, ABCB1/MDR1, TLR4, TNFRSF1A, chromosome 5 risk haplotype including SLC22A4 and SLC22A5, and HLA-DRB1*0103 allele among Finnish IBD patients.
METHODS: A total of 699 IBD patients were genotyped for disease-associated variants by polymerase chain reaction (PCR) and restriction enzyme digestion or Sequenom iPLEX method.
RESULTS: Five markers spanning the IL23R gene were associated with CD. The SNP (single nucleotide polymorphism) rs2201841 gave the strongest association (P = 0.002). The rare HLA-DRB1*0103 allele was found to associate with UC (P = 0.008), and the TNFRSF1A A36G variant was associated with familial UC (P = 0.007). Upon phenotypic analysis we detected association between familial UC and rare TNFRSF1A alleles 36G and IVS6+10G (P = 0.001 and P = 0.042, respectively). In addition, IL23R markers were associated with stricturing CD (P = 0.010-0.017), and ileocolonic CD was more prevalent in the carriers of the same 2 TNFRSF1A variants (P = 0.021 and P = 0.028, respectively). Less significant genotype-phenotype associations were observed for the TLR4 and HLA variants.
CONCLUSIONS: We were able to replicate the association of the IL23R variants with CD as well as HLA-DRB1*0103 with UC; confirmation of TNFRSF1A association with UC needs additional studies. Our findings also suggest that polymorphisms at IL23R and TNFRSF1A, and possibly HLA and TLR4, loci may account for phenotypic variation in IBD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338763     DOI: 10.1002/ibd.20431

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  33 in total

1.  Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Authors:  Jian Wang; Xi Wang; Hong Yang; Dong Wu; Li Wang; Jiaming Qian
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.

Authors:  Jurgita Sventoraityte; Aida Zvirbliene; Andre Franke; Ruta Kwiatkowski; Gediminas Kiudelis; Limas Kupcinskas; Stefan Schreiber
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 3.  The future of molecular approaches to inflammatory bowel disease.

Authors:  Boyko Kabakchiev; Smita Halder; Mark S Silverberg
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 4.  Polymorphisms in HLA-DRB1 gene and the risk of tuberculosis: a meta-analysis of 31 studies.

Authors:  Xiang Tong; Lingmin Chen; Sitong Liu; Zhipeng Yan; Shifeng Peng; Yonggang Zhang; Hong Fan
Journal:  Lung       Date:  2015-02-18       Impact factor: 2.584

Review 5.  Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease.

Authors:  Lynn Cotterill; Debbie Payne; Scott Levinson; John McLaughlin; Emma Wesley; Mark Feeney; Hilary Durbin; Simon Lal; Alistair Makin; Simon Campbell; Stephen A Roberts; Catherine O'Neill; Cathryn Edwards; William G Newman
Journal:  Can J Gastroenterol       Date:  2010-05       Impact factor: 3.522

6.  Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis.

Authors:  Kouichi Asano; Motohiro Esaki; Junji Umeno; Atsushi Hirano; Yuji Maehata; Tomohiko Moriyama; Shotaro Nakamura; Takayuki Matsumoto; Takanari Kitazono
Journal:  J Gastroenterol       Date:  2015-03-19       Impact factor: 7.527

Review 7.  Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.

Authors:  Saleh A Naser; Melissa Arce; Anam Khaja; Marlene Fernandez; Najih Naser; Sammer Elwasila; Saisathya Thanigachalam
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

8.  Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis.

Authors:  Chao Xuan; Bei-Bei Zhang; Tao Yang; Kai-Feng Deng; Ming Li; Rui-Juan Tian
Journal:  Int J Colorectal Dis       Date:  2011-06-25       Impact factor: 2.571

Review 9.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

10.  IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease.

Authors:  Elisabet Einarsdottir; Lotta L E Koskinen; Emma Dukes; Kati Kainu; Sari Suomela; Maarit Lappalainen; Fabiana Ziberna; Ilma R Korponay-Szabo; Kalle Kurppa; Katri Kaukinen; Róza Adány; Zsuzsa Pocsai; György Széles; Martti Färkkilä; Ulla Turunen; Leena Halme; Paulina Paavola-Sakki; Tarcisio Not; Serena Vatta; Alessandro Ventura; Robert Löfberg; Leif Torkvist; Francesca Bresso; Jonas Halfvarson; Markku Mäki; Kimmo Kontula; Ulpu Saarialho-Kere; Juha Kere; Mauro D'Amato; Päivi Saavalainen
Journal:  BMC Med Genet       Date:  2009-01-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.